Literature DB >> 26363521

HLA-DR*0401 expression in the NOD mice prevents the development of autoimmune diabetes by multiple alterations in the T-cell compartment.

Luis Pow Sang1, Jacqueline Surls1, Mirian Mendoza1, Sofia Casares2, Teodor Brumeanu3.   

Abstract

Several human HLA alleles have been found associated with type 1 diabetes (T1D), but their precise role is not clearly defined. Herein, we report that a human MHC class II (HLA-DR*0401) allele transgene that has been expressed into NOD (H-2(g7)I-E(null)) mice prone to T1D rendered the mice resistant to the disease. T1D resistance occurred in the context of multi-point T-cell alterations such as: (i) skewed CD4/CD8 T-cell ratio, (ii) decreased size of CD4(+)CD44(high) T memory pool, (iii) aberrant TCR Vβ repertoire, (iv) increased neonatal number of Foxp3(+) and TR-1(+) regulatory cells, and (v) reduced IFN-γ inflammatory response vs. enhanced IL-10 suppressogenic response of T-cells upon polyclonal and antigen-specific stimulation. The T-cells from NOD/DR4 Tg mice were unable to induce or suppress diabetes in NOD/RAG deficient mice. This study describes a multifaceted regulatory function of the HLA-DR*0401 allele strongly associated with the lack of T1D development in NOD mice. Published by Elsevier Inc.

Entities:  

Keywords:  HLA-DR*0401; NOD humanized mice; T-cell regulation; Type 1 diabetes

Mesh:

Substances:

Year:  2015        PMID: 26363521     DOI: 10.1016/j.cellimm.2015.09.003

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  4 in total

Review 1.  Islet-immune interactions in type 1 diabetes: the nexus of beta cell destruction.

Authors:  L Peters; A Posgai; T M Brusko
Journal:  Clin Exp Immunol       Date:  2019-08-14       Impact factor: 4.330

2.  Nonobese Diabetic (NOD) Mice Lack a Protective B-Cell Response against the "Nonlethal" Plasmodium yoelii 17XNL Malaria Protozoan.

Authors:  Mirian Mendoza; Luis Pow Sang; Qi Qiu; Sofia Casares; Teodor-D Brumeanu
Journal:  Malar Res Treat       Date:  2016-12-15

3.  Proinsulin-mediated induction of type 1 diabetes in HLA-DR4-transgenic mice.

Authors:  Johan Verhagen; Emma L Smith; Emily M Whettlock; Benedict Macintyre; Mark Peakman
Journal:  Sci Rep       Date:  2018-09-20       Impact factor: 4.379

Review 4.  Preclinical Models to Evaluate the Human Response to Autoantigen and Antigen-Specific Immunotherapy in Human Type 1 Diabetes.

Authors:  Pamela Houeiss; Christian Boitard; Sandrine Luce
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-13       Impact factor: 6.055

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.